- Philip Wood, consultant immunologist1,
- Daniel Peckham, consultant respiratory physician2
- 1Department of Clinical Immunology, St James’s University Hospital, Leeds, LS9 7TF
- 2Department of Respiratory Medicine, St James’s University Hospital
- Correspondence to: P Wood philip.wood{at}leedsth.nhs.uk
The patient
A 29 year old man presents to the surgery with a third episode of respiratory tract infection in three months, having had one admission to hospital with proved pneumococcal pneumonia five months ago. He is a previously well non-smoker who does not have asthma, any previous diagnosed chronic medical condition, or recent history of foreign travel.
He has no weight loss or night sweats. On examination he has bilateral basal crackles in the lungs, normal tympanic membranes, no facial tenderness, and no lymphadenopathy or splenomegaly. A full blood count is normal; random and fasting blood glucose, urea, creatinine, and liver enzymes are all normal, and urinalysis is negative for blood and protein. Sputum culture identifies the presence of Haemophilus influenzae. A chest radiograph is reported as normal.
What is the next investigation?
In 2007 the reported prevalence for acute respiratory infections in the United Kingdom was 1599/10 000 population, with peaks in early childhood and in people over 75 years of age. In contrast, the reported prevalence for pneumococcal pneumonia, and for pneumonia due to other causes, was 2/10 000.1 Upper respiratory tract infections are therefore common but are highly unlikely to indicate an underlying medical condition when they occur in isolation. There are no data on what constitutes a “normal” frequency of respiratory infections, and the characteristics of episodes of infection need to be considered.
Patients may have concerns over recurrent infections and their immunological competence. When infections are severe, persist despite standard therapy, recur after treatment is finished or at an unexpected frequency, or where the isolated organism is unusual within the clinical context, further investigation for underlying causes is warranted. Outside these situations, immunodeficiency is unlikely. …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012